A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.
- Resource Type
- Article
- Source
- Cancer Communications; Apr2023, Vol. 43 Issue 4, p503-507, 5p
- Subject
- Language
- ISSN
- 25233548